Experimental vaccine targets mosquito saliva.
Bethesda, Maryland–(ENEWSPF)–February 21, 2017. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria,…
